Skip to main content
main-content

In depth

In depth

13-09-2019 | Axial spondyloarthritis | Feature | Article

A closer look at the US guidelines for managing axSpA

Michael Ward talks about what’s new in the updated US guidelines for the management of ankylosing spondylitis and nonradiographic axial spondyloarthritis.

13-09-2019 | Ankylosing spondylitis | Feature | Article

At a glance: Phase III trials of IL-17A inhibitors in ankylosing spondylitis

A quick-reference guide to the phase III trials of IL-17A inhibitors for the treatment of ankylosing spondylitis.

21-08-2019 | Tofacitinib | Feature | Article

Tofacitinib black box warning: A cause for concern?

Roy Fleischmann puts the new FDA boxed warning of increased pulmonary embolism and death risk with tofacitinib into context for rheumatologists and their patients.

23-07-2019 | Axial spondyloarthritis | Feature | Article

Into the clinic: Certolizumab pegol for nonradiographic axSpA

medwireNews talks to Walter Maksymowych and Marina Magrey about the impact of the recent FDA approval of certolizumab pegol for nonradiographic axial spondyloarthritis, and why the approval happened so much later in the USA than in Europe.

10-06-2019 | Psoriatic arthritis | Feature | Article

A closer look at guidelines for the management of PsA

Laura Coates talks to medwireNews about the latest ACR/NPF guidelines for managing psoriatic arthritis, discussing the evidence supporting the recommendations and how they compare with others.

07-05-2019 | Systemic lupus erythematosus | Podcast | Article

A closer look at the EULAR guidelines for managing lupus

Antonis Fanouriakis, lead author of the updated EULAR guidelines for the management of lupus, talks to medwireNews about what’s new in these guidelines and how they will influence clinical practice.

29-03-2019 | Rheumatoid arthritis | Feature | Article

JAK inhibitors in RA: A round-up of the phase III trials

medwireNews summarizes the completed and ongoing phase III trials of JAK inhibitors in patients with rheumatoid arthritis.

21-02-2019 | Psoriatic arthritis | Feature | Article

The role of JAK inhibitors in the treatment of PsA

Dafna Gladman speaks to medwireNews about the trial data supporting the use of Janus kinase inhibitors in patients with psoriatic arthritis, and discusses the impact these agents may have.

21-02-2019 | Spondyloarthropathies | Feature | Article

Trials of JAK inhibitors in spondyloarthritis: A round-up

medwireNews rounds up the completed and ongoing clinical trials investigating JAK inhibitors in patients with spondyloarthritis.

18-12-2018 | Psoriatic arthritis | Feature | Article

Recognizing and managing cardiovascular risk in PsA patients

medwireNews speaks to Lihi Eder about why patients with psoriatic arthritis have elevated cardiovascular risk, and what can be done to mitigate it.

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

20-08-2018 | Psoriatic arthritis | Feature | Article

At a glance: Data supporting the approval of ixekizumab for PsA

A quick-reference guide to the clinical trial data supporting the approval of ixekizumab for the treatment of psoriatic arthritis.

20-08-2018 | Psoriatic arthritis | Feature | Article

Into the clinic: Ixekizumab for the treatment of PsA

medwireNews summarizes the key data supporting the approval of ixekizumab for the treatment of psoriatic arthritis, and discusses its place in the treatment landscape with Philip Mease and Laura Coates.

13-07-2018 | Juvenile idiopathic arthritis | Podcast | Video

Transitioning from pediatric to adult rheumatology care

In this medwireNews podcast, we talk to Editorial Board member Sangeeta Sule about how patients with juvenile arthritis transition from pediatric to adult care, the challenges associated with this transition, and how the process can be improved.

11-05-2018 | Juvenile idiopathic arthritis | Feature | News

Managing JIA-associated uveitis: An ophthalmologist’s perspective

medwireNews talks to consultant ophthalmologist Carlos Pavesio about the SHARE initiative recommendations on treating JIA-associated uveitis.

09-05-2018 | Juvenile idiopathic arthritis | Podcast | Video

A closer look at the SHARE recommendations

In this medwireNews podcast, Athimalaipet Ramanan outlines the importance of the SHARE recommendations for children with JIA-associated uveitis, and discusses how rheumatologists and ophthalmologists can work together.

06-04-2018 | Spondyloarthropathies | Feature | Article

At a glance: Trials of tofacitinib in spondyloarthritis

A quick-reference guide to the published and ongoing clinical trials of tofacitinib for the treatment of spondyloarthritis.

27-03-2018 | Biosimilars | Podcast | Video

Talking to patients about biosimilar drugs

In this medwireNews podcast, Editorial Board member Victoria Ruffing discusses how to talk to patients about biosimilar drugs, and outlines questions and concerns they may have.

09-02-2018 | Rheumatoid arthritis | Feature | News

Should treatment be tapered in patients with RA?

medwireNews speaks to Vivian Bykerk about whether treatment should be tapered in patients with rheumatoid arthritis.

13-12-2017 | Biosimilars | Feature | Article

Biosimilars: The story so far

medwireNews provides an overview of the evidence supporting the equivalence of biosimilar drugs and their reference products, and answers some questions about the use of biosimilars in rheumatology.

Image Credits